The global market for Modified Release Formulation was valued at US$ 48624 million in the year 2024 and is projected to reach a revised size of US$ 65071 million by 2031, growing at a CAGR of 4.3% during the forecast period.

Modified Release Formulation Market

Modified Release Formulation refers to pharmaceutical systems designed to control the rate, timing, or location of drug release, thereby extending the duration of therapeutic effect, reducing dosing frequency, minimizing adverse reactions, and improving patient compliance. These formulations utilize carrier structure modifications, coating technologies, polymer matrices, or nano-delivery systems to release active ingredients in a predictable manner within the body. Compared with immediate-release formulations, modified release forms ensure more stable plasma concentrations and consistent efficacy. They are widely used in the treatment of CNS disorders, cardiovascular diseases, diabetes, cancer, and chronic pain. With advances in polymer materials, microsphere encapsulation, osmotic pump systems, and oral controlled-release films, modified release formulations have become a major driver for innovation and differentiation in the pharmaceutical market.

With the rising prevalence of chronic diseases and aging populations, modified release formulations have become a key pathway for pharmaceutical companies to enhance product lifecycle value through “long-acting, safe, and convenient” therapeutic features. Regulatory authorities worldwide are encouraging drug delivery innovation for drug redevelopment, boosting the rapid expansion of oral sustained-release tablets, subcutaneous depot injections, and implantable release systems. Global pharmaceutical leaders are strengthening early integration of modified release technologies in R&D through collaborations with material science firms and CDMOs. Moreover, biodegradable polymers, nano-microspheres, liposomes, and solid dispersions are creating new opportunities for long-acting and targeted delivery.

The preparation of modified release formulations involves complex processes and long development cycles, requiring high precision in equipment and process control. Factors such as API particle size, coating uniformity, and polymer stability can influence release profiles, posing quality risks. Regulatory agencies in the US and Europe have raised standards for dissolution curve similarity, bioequivalence validation, and stability testing, increasing registration costs. In addition, patent overlap and market entry barriers hinder technology transfer and reduce competitiveness for small and mid-sized enterprises.

Clinically and commercially, modified release formulations are expanding from traditional oral solids to diverse dosage forms including transdermal patches, long-acting injectables, implants, and smart delivery devices. Patient preference for “fewer doses, higher compliance” is driving formulation innovation focused on patient experience. Both multinational and generic manufacturers use modified release technologies for product differentiation and patent extension, while meeting payer demands for cost-effectiveness. Hospitals and clinicians increasingly prefer sustained-release formulations for chronic disease management due to their improved compliance and safety profile.

The upstream sector primarily includes pharmaceutical-grade polymers (e.g., HPMC, Eudragit, PLGA), functional coating materials, biodegradable carriers, and high-purity solvents. The global supply chain is upgrading toward higher purity, traceability, and environmental compliance. Polymer manufacturers are optimizing molecular weight distribution and viscosity grades to enhance release control. Meanwhile, suppliers in the US, Europe, and Japan lead in regulatory standardization and excipient quality certification, driving global formulation producers toward compliance-oriented supply restructuring.

This report aims to provide a comprehensive presentation of the global market for Modified Release Formulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Modified Release Formulation.

The Modified Release Formulation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Modified Release Formulation market comprehensively. Regional market sizes, concerning products by Type, by Application, by Drugs Type and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Modified Release Formulation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Modified Release Formulation Market Report

Report Metric	Details
Report Name	Modified Release Formulation Market
Accounted market size in year	US$ 48624 million
Forecasted market size in 2031	US$ 65071 million
CAGR	4.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Tablet Injection
Segment by Drugs Type	Brand Drugs Generic Drugs
Segment by Disease	Central Nervous System Diseases Cardiovascular Diseases Diabetes Cancer Chronic Pain Other
Segment by Application	Hospital Retail Pharmacy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, AbbVie, Novartis, Recipharm, Alkermes, Bristol‑Myers Squibb, Boehringer Ingelheim, Bayer, SPH, Novo Nordisk, Sanofi-Aventis, Eli Lilly, Tonghua Dongbao, United Laboratory, Biocon, Torrent Pharma, Amphastar, Ganlee, GSK
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Drugs Type etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Modified Release Formulation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Modified Release Formulation Market growing?

Ans: The Modified Release Formulation Market witnessing a CAGR of 4.3% during the forecast period 2025-2031.

What is the Modified Release Formulation Market size in 2031?

Ans: The Modified Release Formulation Market size in 2031 will be US$ 65071 million.

Who are the main players in the Modified Release Formulation Market report?

Ans: The main players in the Modified Release Formulation Market are Pfizer, AbbVie, Novartis, Recipharm, Alkermes, Bristol‑Myers Squibb, Boehringer Ingelheim, Bayer, SPH, Novo Nordisk, Sanofi-Aventis, Eli Lilly, Tonghua Dongbao, United Laboratory, Biocon, Torrent Pharma, Amphastar, Ganlee, GSK

What are the Application segmentation covered in the Modified Release Formulation Market report?

Ans: The Applications covered in the Modified Release Formulation Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Modified Release Formulation Market report?

Ans: The Types covered in the Modified Release Formulation Market report are Brand Drugs, Generic Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Modified Release Formulation Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Tablet

1.2.3 Injection

1.3 Market by Drugs Type

1.3.1 Global Modified Release Formulation Market Size Growth Rate by Drugs Type: 2020 VS 2024 VS 2031

1.3.2 Brand Drugs

1.3.3 Generic Drugs

1.4 Market by Disease

1.4.1 Global Modified Release Formulation Market Size Growth Rate by Disease: 2020 VS 2024 VS 2031

1.4.2 Central Nervous System Diseases

1.4.3 Cardiovascular Diseases

1.4.4 Diabetes

1.4.5 Cancer

1.4.6 Chronic Pain

1.4.7 Other

1.5 Market by Application

1.5.1 Global Modified Release Formulation Market Growth by Application: 2020 VS 2024 VS 2031

1.5.2 Hospital

1.5.3 Retail Pharmacy

1.5.4 Other

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Modified Release Formulation Market Perspective (2020-2031)

2.2 Global Modified Release Formulation Growth Trends by Region

2.2.1 Global Modified Release Formulation Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Modified Release Formulation Historic Market Size by Region (2020-2025)

2.2.3 Modified Release Formulation Forecasted Market Size by Region (2026-2031)

2.3 Modified Release Formulation Market Dynamics

2.3.1 Modified Release Formulation Industry Trends

2.3.2 Modified Release Formulation Market Drivers

2.3.3 Modified Release Formulation Market Challenges

2.3.4 Modified Release Formulation Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Modified Release Formulation Players by Revenue

3.1.1 Global Top Modified Release Formulation Players by Revenue (2020-2025)

3.1.2 Global Modified Release Formulation Revenue Market Share by Players (2020-2025)

3.2 Global Top Modified Release Formulation Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Modified Release Formulation Revenue

3.4 Global Modified Release Formulation Market Concentration Ratio

3.4.1 Global Modified Release Formulation Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Modified Release Formulation Revenue in 2024

3.5 Global Key Players of Modified Release Formulation Head office and Area Served

3.6 Global Key Players of Modified Release Formulation, Product and Application

3.7 Global Key Players of Modified Release Formulation, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Modified Release Formulation Breakdown Data by Type

4.1 Global Modified Release Formulation Historic Market Size by Type (2020-2025)

4.2 Global Modified Release Formulation Forecasted Market Size by Type (2026-2031)

5 Modified Release Formulation Breakdown Data by Application

5.1 Global Modified Release Formulation Historic Market Size by Application (2020-2025)

5.2 Global Modified Release Formulation Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Modified Release Formulation Market Size (2020-2031)

6.2 North America Modified Release Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Modified Release Formulation Market Size by Country (2020-2025)

6.4 North America Modified Release Formulation Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Modified Release Formulation Market Size (2020-2031)

7.2 Europe Modified Release Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Modified Release Formulation Market Size by Country (2020-2025)

7.4 Europe Modified Release Formulation Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Modified Release Formulation Market Size (2020-2031)

8.2 Asia-Pacific Modified Release Formulation Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Modified Release Formulation Market Size by Region (2020-2025)

8.4 Asia-Pacific Modified Release Formulation Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Modified Release Formulation Market Size (2020-2031)

9.2 Latin America Modified Release Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Modified Release Formulation Market Size by Country (2020-2025)

9.4 Latin America Modified Release Formulation Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Modified Release Formulation Market Size (2020-2031)

10.2 Middle East & Africa Modified Release Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Modified Release Formulation Market Size by Country (2020-2025)

10.4 Middle East & Africa Modified Release Formulation Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Modified Release Formulation Introduction

11.1.4 Pfizer Revenue in Modified Release Formulation Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 AbbVie

11.2.1 AbbVie Company Details

11.2.2 AbbVie Business Overview

11.2.3 AbbVie Modified Release Formulation Introduction

11.2.4 AbbVie Revenue in Modified Release Formulation Business (2020-2025)

11.2.5 AbbVie Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Modified Release Formulation Introduction

11.3.4 Novartis Revenue in Modified Release Formulation Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Recipharm

11.4.1 Recipharm Company Details

11.4.2 Recipharm Business Overview

11.4.3 Recipharm Modified Release Formulation Introduction

11.4.4 Recipharm Revenue in Modified Release Formulation Business (2020-2025)

11.4.5 Recipharm Recent Development

11.5 Alkermes

11.5.1 Alkermes Company Details

11.5.2 Alkermes Business Overview

11.5.3 Alkermes Modified Release Formulation Introduction

11.5.4 Alkermes Revenue in Modified Release Formulation Business (2020-2025)

11.5.5 Alkermes Recent Development

11.6 Bristol‑Myers Squibb

11.6.1 Bristol‑Myers Squibb Company Details

11.6.2 Bristol‑Myers Squibb Business Overview

11.6.3 Bristol‑Myers Squibb Modified Release Formulation Introduction

11.6.4 Bristol‑Myers Squibb Revenue in Modified Release Formulation Business (2020-2025)

11.6.5 Bristol‑Myers Squibb Recent Development

11.7 Boehringer Ingelheim

11.7.1 Boehringer Ingelheim Company Details

11.7.2 Boehringer Ingelheim Business Overview

11.7.3 Boehringer Ingelheim Modified Release Formulation Introduction

11.7.4 Boehringer Ingelheim Revenue in Modified Release Formulation Business (2020-2025)

11.7.5 Boehringer Ingelheim Recent Development

11.8 Bayer

11.8.1 Bayer Company Details

11.8.2 Bayer Business Overview

11.8.3 Bayer Modified Release Formulation Introduction

11.8.4 Bayer Revenue in Modified Release Formulation Business (2020-2025)

11.8.5 Bayer Recent Development

11.9 SPH

11.9.1 SPH Company Details

11.9.2 SPH Business Overview

11.9.3 SPH Modified Release Formulation Introduction

11.9.4 SPH Revenue in Modified Release Formulation Business (2020-2025)

11.9.5 SPH Recent Development

11.10 Novo Nordisk

11.10.1 Novo Nordisk Company Details

11.10.2 Novo Nordisk Business Overview

11.10.3 Novo Nordisk Modified Release Formulation Introduction

11.10.4 Novo Nordisk Revenue in Modified Release Formulation Business (2020-2025)

11.10.5 Novo Nordisk Recent Development

11.11 Sanofi-Aventis

11.11.1 Sanofi-Aventis Company Details

11.11.2 Sanofi-Aventis Business Overview

11.11.3 Sanofi-Aventis Modified Release Formulation Introduction

11.11.4 Sanofi-Aventis Revenue in Modified Release Formulation Business (2020-2025)

11.11.5 Sanofi-Aventis Recent Development

11.12 Eli Lilly

11.12.1 Eli Lilly Company Details

11.12.2 Eli Lilly Business Overview

11.12.3 Eli Lilly Modified Release Formulation Introduction

11.12.4 Eli Lilly Revenue in Modified Release Formulation Business (2020-2025)

11.12.5 Eli Lilly Recent Development

11.13 Tonghua Dongbao

11.13.1 Tonghua Dongbao Company Details

11.13.2 Tonghua Dongbao Business Overview

11.13.3 Tonghua Dongbao Modified Release Formulation Introduction

11.13.4 Tonghua Dongbao Revenue in Modified Release Formulation Business (2020-2025)

11.13.5 Tonghua Dongbao Recent Development

11.14 United Laboratory

11.14.1 United Laboratory Company Details

11.14.2 United Laboratory Business Overview

11.14.3 United Laboratory Modified Release Formulation Introduction

11.14.4 United Laboratory Revenue in Modified Release Formulation Business (2020-2025)

11.14.5 United Laboratory Recent Development

11.15 Biocon

11.15.1 Biocon Company Details

11.15.2 Biocon Business Overview

11.15.3 Biocon Modified Release Formulation Introduction

11.15.4 Biocon Revenue in Modified Release Formulation Business (2020-2025)

11.15.5 Biocon Recent Development

11.16 Torrent Pharma

11.16.1 Torrent Pharma Company Details

11.16.2 Torrent Pharma Business Overview

11.16.3 Torrent Pharma Modified Release Formulation Introduction

11.16.4 Torrent Pharma Revenue in Modified Release Formulation Business (2020-2025)

11.16.5 Torrent Pharma Recent Development

11.17 Amphastar

11.17.1 Amphastar Company Details

11.17.2 Amphastar Business Overview

11.17.3 Amphastar Modified Release Formulation Introduction

11.17.4 Amphastar Revenue in Modified Release Formulation Business (2020-2025)

11.17.5 Amphastar Recent Development

11.18 Ganlee

11.18.1 Ganlee Company Details

11.18.2 Ganlee Business Overview

11.18.3 Ganlee Modified Release Formulation Introduction

11.18.4 Ganlee Revenue in Modified Release Formulation Business (2020-2025)

11.18.5 Ganlee Recent Development

11.19 GSK

11.19.1 GSK Company Details

11.19.2 GSK Business Overview

11.19.3 GSK Modified Release Formulation Introduction

11.19.4 GSK Revenue in Modified Release Formulation Business (2020-2025)

11.19.5 GSK Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Modified Release Formulation Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Tablet

Table 3. Key Players of Injection

Table 4. Global Modified Release Formulation Market Size Growth Rate by Drugs Type (US$ Million): 2020 VS 2024 VS 2031

Table 5. Key Players of Brand Drugs

Table 6. Key Players of Generic Drugs

Table 7. Global Modified Release Formulation Market Size Growth Rate by Disease (US$ Million): 2020 VS 2024 VS 2031

Table 8. Key Players of Central Nervous System Diseases

Table 9. Key Players of Cardiovascular Diseases

Table 10. Key Players of Diabetes

Table 11. Key Players of Cancer

Table 12. Key Players of Chronic Pain

Table 13. Key Players of Other

Table 14. Global Modified Release Formulation Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 15. Global Modified Release Formulation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 16. Global Modified Release Formulation Market Size by Region (2020-2025) & (US$ Million)

Table 17. Global Modified Release Formulation Market Share by Region (2020-2025)

Table 18. Global Modified Release Formulation Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 19. Global Modified Release Formulation Market Share by Region (2026-2031)

Table 20. Modified Release Formulation Market Trends

Table 21. Modified Release Formulation Market Drivers

Table 22. Modified Release Formulation Market Challenges

Table 23. Modified Release Formulation Market Restraints

Table 24. Global Modified Release Formulation Revenue by Players (2020-2025) & (US$ Million)

Table 25. Global Modified Release Formulation Market Share by Players (2020-2025)

Table 26. Global Top Modified Release Formulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Modified Release Formulation as of 2024)

Table 27. Ranking of Global Top Modified Release Formulation Companies by Revenue (US$ Million) in 2024

Table 28. Global 5 Largest Players Market Share by Modified Release Formulation Revenue (CR5 and HHI) & (2020-2025)

Table 29. Global Key Players of Modified Release Formulation, Headquarters and Area Served

Table 30. Global Key Players of Modified Release Formulation, Product and Application

Table 31. Global Key Players of Modified Release Formulation, Date of Enter into This Industry

Table 32. Mergers & Acquisitions, Expansion Plans

Table 33. Global Modified Release Formulation Market Size by Type (2020-2025) & (US$ Million)

Table 34. Global Modified Release Formulation Revenue Market Share by Type (2020-2025)

Table 35. Global Modified Release Formulation Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 36. Global Modified Release Formulation Revenue Market Share by Type (2026-2031)

Table 37. Global Modified Release Formulation Market Size by Application (2020-2025) & (US$ Million)

Table 38. Global Modified Release Formulation Revenue Market Share by Application (2020-2025)

Table 39. Global Modified Release Formulation Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 40. Global Modified Release Formulation Revenue Market Share by Application (2026-2031)

Table 41. North America Modified Release Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. North America Modified Release Formulation Market Size by Country (2020-2025) & (US$ Million)

Table 43. North America Modified Release Formulation Market Size by Country (2026-2031) & (US$ Million)

Table 44. Europe Modified Release Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Europe Modified Release Formulation Market Size by Country (2020-2025) & (US$ Million)

Table 46. Europe Modified Release Formulation Market Size by Country (2026-2031) & (US$ Million)

Table 47. Asia-Pacific Modified Release Formulation Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 48. Asia-Pacific Modified Release Formulation Market Size by Region (2020-2025) & (US$ Million)

Table 49. Asia-Pacific Modified Release Formulation Market Size by Region (2026-2031) & (US$ Million)

Table 50. Latin America Modified Release Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 51. Latin America Modified Release Formulation Market Size by Country (2020-2025) & (US$ Million)

Table 52. Latin America Modified Release Formulation Market Size by Country (2026-2031) & (US$ Million)

Table 53. Middle East & Africa Modified Release Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 54. Middle East & Africa Modified Release Formulation Market Size by Country (2020-2025) & (US$ Million)

Table 55. Middle East & Africa Modified Release Formulation Market Size by Country (2026-2031) & (US$ Million)

Table 56. Pfizer Company Details

Table 57. Pfizer Business Overview

Table 58. Pfizer Modified Release Formulation Product

Table 59. Pfizer Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)

Table 60. Pfizer Recent Development

Table 61. AbbVie Company Details

Table 62. AbbVie Business Overview

Table 63. AbbVie Modified Release Formulation Product

Table 64. AbbVie Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)

Table 65. AbbVie Recent Development

Table 66. Novartis Company Details

Table 67. Novartis Business Overview

Table 68. Novartis Modified Release Formulation Product

Table 69. Novartis Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)

Table 70. Novartis Recent Development

Table 71. Recipharm Company Details

Table 72. Recipharm Business Overview

Table 73. Recipharm Modified Release Formulation Product

Table 74. Recipharm Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)

Table 75. Recipharm Recent Development

Table 76. Alkermes Company Details

Table 77. Alkermes Business Overview

Table 78. Alkermes Modified Release Formulation Product

Table 79. Alkermes Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)

Table 80. Alkermes Recent Development

Table 81. Bristol‑Myers Squibb Company Details

Table 82. Bristol‑Myers Squibb Business Overview

Table 83. Bristol‑Myers Squibb Modified Release Formulation Product

Table 84. Bristol‑Myers Squibb Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)

Table 85. Bristol‑Myers Squibb Recent Development

Table 86. Boehringer Ingelheim Company Details

Table 87. Boehringer Ingelheim Business Overview

Table 88. Boehringer Ingelheim Modified Release Formulation Product

Table 89. Boehringer Ingelheim Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)

Table 90. Boehringer Ingelheim Recent Development

Table 91. Bayer Company Details

Table 92. Bayer Business Overview

Table 93. Bayer Modified Release Formulation Product

Table 94. Bayer Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)

Table 95. Bayer Recent Development

Table 96. SPH Company Details

Table 97. SPH Business Overview

Table 98. SPH Modified Release Formulation Product

Table 99. SPH Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)

Table 100. SPH Recent Development

Table 101. Novo Nordisk Company Details

Table 102. Novo Nordisk Business Overview

Table 103. Novo Nordisk Modified Release Formulation Product

Table 104. Novo Nordisk Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)

Table 105. Novo Nordisk Recent Development

Table 106. Sanofi-Aventis Company Details

Table 107. Sanofi-Aventis Business Overview

Table 108. Sanofi-Aventis Modified Release Formulation Product

Table 109. Sanofi-Aventis Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)

Table 110. Sanofi-Aventis Recent Development

Table 111. Eli Lilly Company Details

Table 112. Eli Lilly Business Overview

Table 113. Eli Lilly Modified Release Formulation Product

Table 114. Eli Lilly Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)

Table 115. Eli Lilly Recent Development

Table 116. Tonghua Dongbao Company Details

Table 117. Tonghua Dongbao Business Overview

Table 118. Tonghua Dongbao Modified Release Formulation Product

Table 119. Tonghua Dongbao Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)

Table 120. Tonghua Dongbao Recent Development

Table 121. United Laboratory Company Details

Table 122. United Laboratory Business Overview

Table 123. United Laboratory Modified Release Formulation Product

Table 124. United Laboratory Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)

Table 125. United Laboratory Recent Development

Table 126. Biocon Company Details

Table 127. Biocon Business Overview

Table 128. Biocon Modified Release Formulation Product

Table 129. Biocon Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)

Table 130. Biocon Recent Development

Table 131. Torrent Pharma Company Details

Table 132. Torrent Pharma Business Overview

Table 133. Torrent Pharma Modified Release Formulation Product

Table 134. Torrent Pharma Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)

Table 135. Torrent Pharma Recent Development

Table 136. Amphastar Company Details

Table 137. Amphastar Business Overview

Table 138. Amphastar Modified Release Formulation Product

Table 139. Amphastar Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)

Table 140. Amphastar Recent Development

Table 141. Ganlee Company Details

Table 142. Ganlee Business Overview

Table 143. Ganlee Modified Release Formulation Product

Table 144. Ganlee Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)

Table 145. Ganlee Recent Development

Table 146. GSK Company Details

Table 147. GSK Business Overview

Table 148. GSK Modified Release Formulation Product

Table 149. GSK Revenue in Modified Release Formulation Business (2020-2025) & (US$ Million)

Table 150. GSK Recent Development

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

Table 154. Authors List of This Report

List of Figures

Figure 1. Modified Release Formulation Picture

Figure 2. Global Modified Release Formulation Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Modified Release Formulation Market Share by Type: 2024 VS 2031

Figure 4. Tablet Features

Figure 5. Injection Features

Figure 6. Global Modified Release Formulation Market Size Comparison by Drugs Type (2020-2031) & (US$ Million)

Figure 7. Brand Drugs Features

Figure 8. Generic Drugs Features

Figure 9. Global Modified Release Formulation Market Size Comparison by Disease (2020-2031) & (US$ Million)

Figure 10. Central Nervous System Diseases Features

Figure 11. Cardiovascular Diseases Features

Figure 12. Diabetes Features

Figure 13. Cancer Features

Figure 14. Chronic Pain Features

Figure 15. Other Features

Figure 16. Global Modified Release Formulation Market Size by Application (2020-2031) & (US$ Million)

Figure 17. Global Modified Release Formulation Market Share by Application: 2024 VS 2031

Figure 18. Hospital Case Studies

Figure 19. Retail Pharmacy Case Studies

Figure 20. Other Case Studies

Figure 21. Modified Release Formulation Report Years Considered

Figure 22. Global Modified Release Formulation Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 23. Global Modified Release Formulation Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 24. Global Modified Release Formulation Market Share by Region: 2024 VS 2031

Figure 25. Global Modified Release Formulation Market Share by Players in 2024

Figure 26. Global Modified Release Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 27. The Top 10 and 5 Players Market Share by Modified Release Formulation Revenue in 2024

Figure 28. North America Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. North America Modified Release Formulation Market Share by Country (2020-2031)

Figure 30. United States Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Canada Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Europe Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Europe Modified Release Formulation Market Share by Country (2020-2031)

Figure 34. Germany Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. France Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. U.K. Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Italy Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Russia Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Ireland Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Asia-Pacific Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Asia-Pacific Modified Release Formulation Market Share by Region (2020-2031)

Figure 42. China Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Japan Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. South Korea Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Southeast Asia Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. India Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Australia & New Zealand Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Latin America Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Latin America Modified Release Formulation Market Share by Country (2020-2031)

Figure 50. Mexico Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Brazil Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Middle East & Africa Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Middle East & Africa Modified Release Formulation Market Share by Country (2020-2031)

Figure 54. Israel Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. UAE Modified Release Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. Pfizer Revenue Growth Rate in Modified Release Formulation Business (2020-2025)

Figure 58. AbbVie Revenue Growth Rate in Modified Release Formulation Business (2020-2025)

Figure 59. Novartis Revenue Growth Rate in Modified Release Formulation Business (2020-2025)

Figure 60. Recipharm Revenue Growth Rate in Modified Release Formulation Business (2020-2025)

Figure 61. Alkermes Revenue Growth Rate in Modified Release Formulation Business (2020-2025)

Figure 62. Bristol‑Myers Squibb Revenue Growth Rate in Modified Release Formulation Business (2020-2025)

Figure 63. Boehringer Ingelheim Revenue Growth Rate in Modified Release Formulation Business (2020-2025)

Figure 64. Bayer Revenue Growth Rate in Modified Release Formulation Business (2020-2025)

Figure 65. SPH Revenue Growth Rate in Modified Release Formulation Business (2020-2025)

Figure 66. Novo Nordisk Revenue Growth Rate in Modified Release Formulation Business (2020-2025)

Figure 67. Sanofi-Aventis Revenue Growth Rate in Modified Release Formulation Business (2020-2025)

Figure 68. Eli Lilly Revenue Growth Rate in Modified Release Formulation Business (2020-2025)

Figure 69. Tonghua Dongbao Revenue Growth Rate in Modified Release Formulation Business (2020-2025)

Figure 70. United Laboratory Revenue Growth Rate in Modified Release Formulation Business (2020-2025)

Figure 71. Biocon Revenue Growth Rate in Modified Release Formulation Business (2020-2025)

Figure 72. Torrent Pharma Revenue Growth Rate in Modified Release Formulation Business (2020-2025)

Figure 73. Amphastar Revenue Growth Rate in Modified Release Formulation Business (2020-2025)

Figure 74. Ganlee Revenue Growth Rate in Modified Release Formulation Business (2020-2025)

Figure 75. GSK Revenue Growth Rate in Modified Release Formulation Business (2020-2025)

Figure 76. Bottom-up and Top-down Approaches for This Report

Figure 77. Data Triangulation

Figure 78. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions